Skip to main content
QUCY
NASDAQ Life Sciences

Quantum Cyber N.V. Expands ATM Program to $100M, CFO Transitions to Consulting Role

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$0.363
Mkt Cap
$4.548M
52W Low
$0.34
52W High
$2.64
Market data snapshot near publication time

summarizeSummary

Quantum Cyber N.V. significantly increased its At-The-Market (ATM) equity offering program to $100 million, a substantial potential dilution relative to its market cap, while its CFO transitioned to a consulting agreement with a $20,000 monthly retainer.


check_boxKey Events

  • ATM Program Expanded to $100 Million

    The company amended its Equity Distribution Agreement with Maxim Group LLC, increasing the aggregate offering amount of ordinary shares that can be sold from $10 million to $100 million. This is an update to an existing program established on October 3, 2025, and represents a potential dilution significantly exceeding the company's current market capitalization.

  • CFO Transitions to Consulting Agreement

    William Caragol, the Chief Financial Officer, entered into a consulting agreement effective April 22, 2026, to continue providing financial and accounting services. He will receive a monthly retainer of $20,000, with potential for stock or option grants. This transition marks a change in executive structure and introduces a significant ongoing operational cost relative to the company's size.


auto_awesomeAnalysis

Quantum Cyber N.V. has significantly expanded its At-The-Market (ATM) equity program to $100 million, a move that represents an extremely high potential for dilution given the company's current market capitalization. This follows a recent highly dilutive $6 million private placement and the company's prior disclosure of substantial doubt about its ability to continue as a going concern. The massive increase in the ATM program signals an urgent need for capital, likely at terms highly unfavorable to existing shareholders. Additionally, the company's CFO has transitioned to a consulting agreement with a monthly retainer of $20,000, which is a notable expense for a company of this size and financial standing, raising questions about executive stability and operational costs.

At the time of this filing, QUCY was trading at $0.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.5M. The 52-week trading range was $0.34 to $2.64. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed QUCY - Latest Insights

QUCY
May 08, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
QUCY
May 08, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
QUCY
Apr 28, 2026, 5:29 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
QUCY
Apr 28, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
9
QUCY
Apr 28, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
9
QUCY
Apr 15, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
9
QUCY
Mar 31, 2026, 5:27 PM EDT
Filing Type: 10-K
Importance Score:
9
QUCY
Mar 25, 2026, 5:00 PM EDT
Filing Type: DEF 14A
Importance Score:
10
QUCY
Mar 25, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
QUCY
Mar 17, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9